ChromaDex shares are trading higher after the company reported a year-over-year increase in Q3 EPS results and raised its FY24 revenue guidance.
Portfolio Pulse from Benzinga Newsdesk
ChromaDex shares rose following a year-over-year increase in Q3 EPS and an upward revision of its FY24 revenue guidance.

October 31, 2024 | 8:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ChromaDex shares increased due to a positive Q3 EPS report and an upward revision of FY24 revenue guidance.
The increase in Q3 EPS and the raised FY24 revenue guidance are strong indicators of ChromaDex's financial health and growth potential, likely boosting investor confidence and driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100